These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28916678)

  • 1. GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
    Li P; Wuthrick E; Rappaport JA; Kraft C; Lin JE; Marszalowicz G; Snook AE; Zhan T; Hyslop TM; Waldman SA
    Cancer Res; 2017 Sep; 77(18):5095-5106. PubMed ID: 28916678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
    Lin JE; Colon-Gonzalez F; Blomain E; Kim GW; Aing A; Stoecker B; Rock J; Snook AE; Zhan T; Hyslop TM; Tomczak M; Blumberg RS; Waldman SA
    Cancer Res; 2016 Jan; 76(2):339-46. PubMed ID: 26773096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanylyl cyclase C signaling axis and colon cancer prevention.
    Pattison AM; Merlino DJ; Blomain ES; Waldman SA
    World J Gastroenterol; 2016 Sep; 22(36):8070-7. PubMed ID: 27688649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
    Valentino MA; Lin JE; Snook AE; Li P; Kim GW; Marszalowicz G; Magee MS; Hyslop T; Schulz S; Waldman SA
    J Clin Invest; 2011 Sep; 121(9):3578-88. PubMed ID: 21865642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
    Wilson C; Lin JE; Li P; Snook AE; Gong J; Sato T; Liu C; Girondo MA; Rui H; Hyslop T; Waldman SA
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2328-37. PubMed ID: 25304930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
    Lin JE; Li P; Snook AE; Schulz S; Dasgupta A; Hyslop TM; Gibbons AV; Marszlowicz G; Pitari GM; Waldman SA
    Gastroenterology; 2010 Jan; 138(1):241-54. PubMed ID: 19737566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calorie-induced ER stress suppresses uroguanylin satiety signaling in diet-induced obesity.
    Kim GW; Lin JE; Snook AE; Aing AS; Merlino DJ; Li P; Waldman SA
    Nutr Diabetes; 2016 May; 6(5):e211. PubMed ID: 27214655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis.
    Blomain ES; Rappaport JA; Pattison AM; Bashir B; Caparosa E; Stem J; Snook AE; Waldman SA
    Cancer Biol Ther; 2020 May; 21(5):441-451. PubMed ID: 32037952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C.
    Romi H; Cohen I; Landau D; Alkrinawi S; Yerushalmi B; Hershkovitz R; Newman-Heiman N; Cutting GR; Ofir R; Sivan S; Birk OS
    Am J Hum Genet; 2012 May; 90(5):893-9. PubMed ID: 22521417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins.
    Pattison AM; Blomain ES; Merlino DJ; Wang F; Crissey MA; Kraft CL; Rappaport JA; Snook AE; Lynch JP; Waldman SA
    Infect Immun; 2016 Oct; 84(10):3083-91. PubMed ID: 27481254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.
    Blomain ES; Merlino DJ; Pattison AM; Snook AE; Waldman SA
    Mol Pharmacol; 2016 Sep; 90(3):199-204. PubMed ID: 27251363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.
    Yarla NS; Gali H; Pathuri G; Smriti S; Farooqui M; Panneerselvam J; Kumar G; Madka V; Rao CV
    Semin Cancer Biol; 2019 Jun; 56():168-174. PubMed ID: 30189250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.
    Gibbons AV; Lin JE; Kim GW; Marszalowicz GP; Li P; Stoecker BA; Blomain ES; Rattan S; Snook AE; Schulz S; Waldman SA
    Cancer Res; 2013 Nov; 73(22):6654-66. PubMed ID: 24085786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis.
    Garin-Laflam MP; Steinbrecher KA; Rudolph JA; Mao J; Cohen MB
    Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G740-9. PubMed ID: 19221018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can colorectal cancer be prevented or treated by oral hormone replacement therapy?
    Li P; Lin JE; Schulz S; Pitari GM; Waldman SA
    Curr Mol Pharmacol; 2009 Nov; 2(3):285-92. PubMed ID: 20021465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GUCY2C: at the intersection of obesity and cancer.
    Kim GW; Lin JE; Waldman SA
    Trends Endocrinol Metab; 2013 Apr; 24(4):165-73. PubMed ID: 23375388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
    Weinberg DS; Lin JE; Foster NR; Della'Zanna G; Umar A; Seisler D; Kraft WK; Kastenberg DM; Katz LC; Limburg PJ; Waldman SA
    Cancer Prev Res (Phila); 2017 Jun; 10(6):345-354. PubMed ID: 28396341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uroguanylin: how the gut got another satiety hormone.
    Seeley RJ; Tschöp MH
    J Clin Invest; 2011 Sep; 121(9):3384-6. PubMed ID: 21865649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
    Aka AA; Rappaport JA; Pattison AM; Sato T; Snook AE; Waldman SA
    Expert Rev Clin Pharmacol; 2017 May; 10(5):549-557. PubMed ID: 28162021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases.
    Jarmuż A; Zielińska M; Storr M; Fichna J
    Neurogastroenterol Motil; 2015 Aug; 27(8):1057-68. PubMed ID: 25930667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.